{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:24:35Z","timestamp":1786627475849,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The burden of post-coronavirus disease (COVID)-19 symptoms has been increasing and is of great concern in patients with pre-existing chronic medical conditions.This study aimed to delineate the post-COVID-19 neuropsychiatric symptoms among migraine patients compared to the non-migraine control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two groups, each of 204 COVID-19 survivors, were enrolled in the study after 3\u00a0months of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, one group fulfilling the episodic migraine criteria and the other serving as a matching control group. Subjects were evaluated through an in-person interview for post-COVID-19 neuropsychiatric symptoms, including detailed headache patterns and severity, using the visual analogue scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The Frequency of headache during the acute phase of COVID-19 was more frequent in migraine patients (OR\u2009=\u20091.60, 95%CI\u2009=\u20091.04\u20132.45, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.031). The reported significant post-COVID-19 neuropsychiatric symptoms in migraine patients compared to controls were fatigue (OR\u2009=\u20091.662, 95%CI\u2009=\u20091.064\u20132.596, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.025), anosmia\/hyposmia (OR\u2009=\u20092.06, 95%CI\u2009=\u20091.164- 3.645, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.012), cacosmia (OR\u2009=\u20092.663, 95%CI\u2009=\u20091.145\u20136.195, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.019), depression (OR\u2009=\u20092.259, 95%CI\u2009=\u20091.284- 3.975, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.004), anxiety (OR\u2009=\u20093.267, 95%CI\u2009=\u20091.747- 6.108, <jats:italic>P-<\/jats:italic>value\u2009\u2264\u20090.001), insomnia (OR\u2009=\u20092.203, 95%CI\u2009=\u20091.298- 3.739, <jats:italic>P-<\/jats:italic>value\u2009=\u20090.003), and headache (OR\u2009=\u20093.148, 95%CI\u2009=\u20091.616\u20136.136, <jats:italic>P-<\/jats:italic>value\u2009=\u2009\u2009\u2264\u20090.001).While there was no statistically significant difference between migraine patients and controls regarding the post-COVID-19 functional status score (<jats:italic>P-<\/jats:italic>value\u2009=\u20090.102). The pattern of post-COVID-19 headache was reported as chronic headache transformation in 17.6% of the migraine group, with the median intensity rate being 5.5 and IQR (3\u20137). In the control group, 14% experienced chronic headache attributed to systemic viral infection with a median intensity rate of 2 and IQR (2\u20135), while 12% experienced a new daily persistent headache with a median intensity of 5 and IQR (1\u20136).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study highlighted the importance of follow-up migraine patients upon recovery from COVID-19 infection, being more vulnerable to post-COVID-19 symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-022-01468-y","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T10:05:01Z","timestamp":1660298701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case\u2013control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Rehab","family":"Magdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Elmazny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa H.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H.","family":"Elsebaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Abdel Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yassien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa M.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda M.","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"1","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12995-021-00337-9","volume":"16","author":"C Lemh\u00f6fer","year":"2021","unstructured":"Lemh\u00f6fer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C (2021) The impact of Post-COVID-Syndrome on functioning \u2013 results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol 16(1):45. https:\/\/doi.org\/10.1186\/s12995-021-00337-9","journal-title":"J Occup Med Toxicol"},{"key":"1468_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejim.2021.06.009","volume":"92","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G et al (2021) Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med 92:55\u201370. https:\/\/doi.org\/10.1016\/j.ejim.2021.06.009","journal-title":"Eur J Intern Med"},{"issue":"10","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 53(10):737\u2013754. https:\/\/doi.org\/10.1080\/23744235.2021.1924397","journal-title":"Infect Dis (Lond)"},{"key":"1468_CR4","doi-asserted-by":"publisher","unstructured":"Proal AD, VanElzakker MB (2021) Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol 12. https:\/\/doi.org\/10.3389\/fmicb.2021.698169.","DOI":"10.3389\/fmicb.2021.698169"},{"key":"1468_CR5","doi-asserted-by":"publisher","unstructured":"Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ (2020) The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.01991.","DOI":"10.3389\/fimmu.2020.01991"},{"issue":"1","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43166-021-00104-y","volume":"49","author":"DM Gamal","year":"2022","unstructured":"Gamal DM, Ibrahim RA, Samaan SF (2022) Post COVID-19 syndrome in a prospective cohort study of Egyptian patients. Egypt RheumatolRehab 49(1):12. https:\/\/doi.org\/10.1186\/s43166-021-00104-y","journal-title":"Egypt RheumatolRehab"},{"key":"1468_CR7","doi-asserted-by":"publisher","unstructured":"Karsan N, Goadsby PJ (2021) Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?. Front Hum Neurosci 15. https:\/\/doi.org\/10.3389\/fnhum.2021.646692.","DOI":"10.3389\/fnhum.2021.646692"},{"key":"1468_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/ndt.s8467","volume":"6","author":"M Pompili","year":"2010","unstructured":"Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D et al (2010) Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 6:81\u201391. https:\/\/doi.org\/10.2147\/ndt.s8467","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1468_CR9","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, G\u00f3mez-Mayordomo V (2021) The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study 41(13):1332\u201341. https:\/\/doi.org\/10.1177\/03331024211020404.","DOI":"10.1177\/03331024211020404"},{"issue":"9","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/pm\/pnab020","volume":"22","author":"M Hussein","year":"2021","unstructured":"Hussein M, Fathy W, Eid RA, Abdel-Hamid HM, Yehia A, Sheemy MS et al (2021) Relative frequency and risk factors of COVID-19 related headache in a sample of Egyptian population: a hospital-based study. Pain Med (Malden, Mass) 22(9):2092\u20132099. https:\/\/doi.org\/10.1093\/pm\/pnab020","journal-title":"Pain Med (Malden, Mass)"},{"key":"1468_CR11","doi-asserted-by":"publisher","first-page":"678472","DOI":"10.3389\/fnhum.2021.678472","volume":"15","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, G\u00f3mez-Mayordomo V, Garc\u00eda-Azor\u00edn D, Palacios-Ce\u00f1a D, Florencio LL, Guerrero AL et al (2021) Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a case-control study. Front Hum Neurosci 15:678472. https:\/\/doi.org\/10.3389\/fnhum.2021.678472","journal-title":"Front Hum Neurosci"},{"issue":"12","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 12(12):1495\u20131499. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","journal-title":"Int J Surg (London, England)"},{"key":"1468_CR13","unstructured":"WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. COVID-19: Clinical care. 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1."},{"key":"1468_CR14","volume-title":"Clinical management of COVID-19: Interim guidance","author":"Organization WH","year":"2020","unstructured":"Organization WH (2020) Clinical management of COVID-19: Interim guidance"},{"key":"1468_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Stay Up to Date with Your COVID-19 Vaccines. COVID-19. 2022. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html."},{"key":"1468_CR16","doi-asserted-by":"publisher","unstructured":"The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. https:\/\/doi.org\/10.1177\/0333102413485658.","DOI":"10.1177\/0333102413485658"},{"issue":"11","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2015.1346","volume":"313","author":"EW Clayton","year":"2015","unstructured":"Clayton EW (2015) Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA 313(11):1101\u20131102. https:\/\/doi.org\/10.1001\/jama.2015.1346","journal-title":"JAMA"},{"issue":"Suppl 1","key":"1468_CR18","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_97_17","volume":"11","author":"AS Terkawi","year":"2017","unstructured":"Terkawi AS, Abolkhair A, Didier B, Alzhahrani T, Alsohaibani M, Terkawi YS et al (2017) Development and validation of Arabic version of the douleur neuropathique 4 questionnaire. Saudi J Anaesth 11(Suppl 1):S31\u2013S39. https:\/\/doi.org\/10.4103\/sja.SJA_97_17","journal-title":"Saudi J Anaesth"},{"key":"1468_CR19","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Arlington: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/gps.5227","volume":"35","author":"G Dautzenberg","year":"2020","unstructured":"Dautzenberg G, Lijmer J, Beekman A (2020) Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls. Int J Geriatr Psychiatry 35(3):261\u20139. https:\/\/doi.org\/10.1002\/gps.5227","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1468_CR21","doi-asserted-by":"publisher","first-page":"2001494","DOI":"10.1183\/13993003.01494-2020","volume":"56","author":"FA Klok","year":"2020","unstructured":"Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S et al (2020) The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 56(1):2001494. https:\/\/doi.org\/10.1183\/13993003.01494-2020","journal-title":"Eur Respir J"},{"key":"1468_CR22","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.neurop.2021.10.003","volume":"1","author":"JA Membrilla","year":"2021","unstructured":"Membrilla JA, Caronna E, Trigo-L\u00f3pez J, Gonz\u00e1lez-Mart\u00ednez A, Layos-Romero A, Pozo-Rosich P et al (2021) Persistent headache after COVID-19: Pathophysioloy, clinic and treatment. Neurology Perspectives 1:S31\u2013S36. https:\/\/doi.org\/10.1016\/j.neurop.2021.10.003","journal-title":"Neurology Perspectives"},{"key":"1468_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"372","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel YW, Cowan RP (2017) Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 372:307\u2013315. https:\/\/doi.org\/10.1016\/j.jns.2016.11.071","journal-title":"J Neurol Sci"},{"issue":"4","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al (2021) Attributes and predictors of long COVID. Nat Med 27(4):626\u2013631. https:\/\/doi.org\/10.1038\/s41591-021-01292-y","journal-title":"Nat Med"},{"issue":"4","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmi.2021.11.002","volume":"28","author":"F Bai","year":"2022","unstructured":"Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul\u00e8 G et al (2022) Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 28(4):611. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.002","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/brainsci12020154","volume":"12","author":"A Di Stadio","year":"2022","unstructured":"Di Stadio A, Brenner MJ, De Luca P, Albanese M, D\u2019Ascanio L, Ralli M et al (2022) Olfactory dysfunction, headache, and mental clouding in adults with long-COVID-19: what is the link between cognition and olfaction? a cross-sectional study. Brain Sci 12(2):154. https:\/\/doi.org\/10.3390\/brainsci12020154","journal-title":"Brain Sci"},{"issue":"1","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10072-018-3597-6","volume":"40","author":"T Akt\u00fcrk","year":"2019","unstructured":"Akt\u00fcrk T, Tan\u0131k N, Serin H, Sa\u00e7mac\u0131 H, \u0130nan LE (2019) Olfactory bulb atrophy in migraine patients. Neurol Sci 40(1):127\u2013132. https:\/\/doi.org\/10.1007\/s10072-018-3597-6","journal-title":"Neurol Sci"},{"key":"1468_CR28","doi-asserted-by":"publisher","first-page":"100284","DOI":"10.1016\/j.jcte.2021.100284","volume":"27","author":"R Bansal","year":"2022","unstructured":"Bansal R, Gubbi S, Koch CA (2022) COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol 27:100284. https:\/\/doi.org\/10.1016\/j.jcte.2021.100284","journal-title":"J Clin Transl Endocrinol"},{"key":"1468_CR29","doi-asserted-by":"publisher","unstructured":"Mackay A. A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME\/CFS. Front Neurol. 2021;12. https:\/\/doi.org\/10.3389\/fneur.2021.701419.","DOI":"10.3389\/fneur.2021.701419"},{"issue":"12","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/brainsci10121012","volume":"10","author":"T Rudroff","year":"2020","unstructured":"Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J (2020) Post-COVID-19 fatigue: potential contributing factors. Brain Sci 10(12):1012. https:\/\/doi.org\/10.3390\/brainsci10121012","journal-title":"Brain Sci"},{"issue":"6","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jnnp.71.6.747","volume":"71","author":"MF Peres","year":"2001","unstructured":"Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J et al (2001) Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 71(6):747\u201351. https:\/\/doi.org\/10.1136\/jnnp.71.6.747","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1046\/j.1468-2982.2002.00426.x","volume":"22","author":"MF Peres","year":"2002","unstructured":"Peres MF, Zukerman E, Young WB, Silberstein SD (2002) Fatigue in chronic migraine patients. Cephalalgia 22(9):720\u2013724. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00426.x","journal-title":"Cephalalgia"},{"issue":"1","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejpsy.2020.10.004","volume":"35","author":"L Attademo","year":"2021","unstructured":"Attademo L, Bernardini F (2021) Are dopamine and serotonin involved in COVID-19 pathophysiology? Eur J Psychiatry 35(1):62\u201363. https:\/\/doi.org\/10.1016\/j.ejpsy.2020.10.004","journal-title":"Eur J Psychiatry"},{"key":"1468_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2398212818799269","volume":"2","author":"A Kaltenboeck","year":"2018","unstructured":"Kaltenboeck A, Harmer C (2018) The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain Neurosci Adv 2:1\u20136","journal-title":"Brain Neurosci Adv"},{"issue":"3","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/0333102416640501","volume":"37","author":"M Deen","year":"2017","unstructured":"Deen M, Christensen CE, Hougaard A, Hansen HD, Knudsen GM, Ashina M (2017) Serotonergic mechanisms in the migraine brain - a systematic review. Cephalalgia 37(3):251\u2013264. https:\/\/doi.org\/10.1177\/0333102416640501","journal-title":"Cephalalgia"},{"issue":"3","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"e2109-e","DOI":"10.1002\/rmv.2109","volume":"30","author":"G Anderson","year":"2020","unstructured":"Anderson G, Reiter RJ (2020) Melatonin: Roles in influenza, Covid-19, and other viral infections. Rev Med Virol 30(3):e2109-e. https:\/\/doi.org\/10.1002\/rmv.2109","journal-title":"Rev Med Virol"},{"key":"1468_CR37","doi-asserted-by":"publisher","unstructured":"Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis. Headache: The Journal of Head and Face Pain. 2020;60(7):1273\u201399. https:\/\/doi.org\/10.1111\/head.13828.","DOI":"10.1111\/head.13828"},{"issue":"8","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/head.14197","volume":"61","author":"E Caronna","year":"2021","unstructured":"Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P (2021) Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache 61(8):1277\u201380. https:\/\/doi.org\/10.1111\/head.14197","journal-title":"Headache"},{"key":"1468_CR39","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Navarro-Santana M, G\u00f3mez-Mayordomo V. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. 2021;28(11):3820\u20135. https:\/\/doi.org\/10.1111\/ene.15040.","DOI":"10.1111\/ene.15040"},{"key":"1468_CR40","doi-asserted-by":"publisher","unstructured":"Garcia-Azorin D, Layos-Romero A. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. 2022;42(8):804\u20139. https:\/\/doi.org\/10.1177\/03331024211068074.","DOI":"10.1177\/03331024211068074"},{"key":"1468_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.656313","volume":"15","author":"H Yapici-Eser","year":"2021","unstructured":"Yapici-Eser H, Koroglu YE, OztoP-Cakmak O, Keskin O, Gursoy A, Gursoy-Ozdemir Y (2021) Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins\u2019 Mimicry of Human Protein Interactions. Front Hum Neurosci 15:656313. https:\/\/doi.org\/10.3389\/fnhum.2021.656313","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-021-01263-1","volume":"22","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Takeshima T, Igarashi H, Imai N, Danno D, Yamamoto T et al (2021) Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study. J Headache Pain 22(1):53. https:\/\/doi.org\/10.1186\/s10194-021-01263-1","journal-title":"J Headache Pain"},{"issue":"1","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","volume":"21","author":"JY Al-Hashel","year":"2020","unstructured":"Al-Hashel JY, Ismail II (2020) Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain 21(1):115. https:\/\/doi.org\/10.1186\/s10194-020-01183-6","journal-title":"J Headache Pain"},{"key":"1468_CR44","doi-asserted-by":"publisher","unstructured":"Yin JH, Lin YK. Prevalence and association of lifestyle and medical-, psychiatric-, and pain-related comorbidities in patients with migraine: a cross-sectional study. 2021;61(5):715-26. https:\/\/doi.org\/10.1111\/head.14106.","DOI":"10.1111\/head.14106"},{"issue":"4","key":"1468_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","volume":"81","author":"DC Buse","year":"2010","unstructured":"Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81(4):428. https:\/\/doi.org\/10.1136\/jnnp.2009.192492","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Z Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB (2012) Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 16(1):86\u201392. https:\/\/doi.org\/10.1007\/s11916-011-0233-z","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1468_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-018-0916-5","volume":"19","author":"J Kim","year":"2018","unstructured":"Kim J, Cho S-J, Kim W-J, Yang KI, Yun C-H, Chu MK (2018) Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain 19(1):86. https:\/\/doi.org\/10.1186\/s10194-018-0916-5","journal-title":"J Headache Pain"},{"issue":"3","key":"1468_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10194-010-0199-y","volume":"11","author":"WF Yeung","year":"2010","unstructured":"Yeung WF, Chung KF, Wong CY (2010) Relationship between insomnia and headache in community-based middle-aged Hong Kong Chinese women. J Headache Pain 11(3):187\u2013195. https:\/\/doi.org\/10.1007\/s10194-010-0199-y","journal-title":"J Headache Pain"},{"issue":"7","key":"1468_CR49","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/head.13342","volume":"58","author":"RB Lipton","year":"2018","unstructured":"Lipton RB, Fanning KM, Buse DC, Martin VT, Reed ML, Manack Adams A et al (2018) Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache 58(7):933\u201347. https:\/\/doi.org\/10.1111\/head.13342","journal-title":"Headache"},{"issue":"8","key":"1468_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamaoto.2018.0939","volume":"144","author":"J-H Hwang","year":"2018","unstructured":"Hwang J-H, Tsai S-J, Liu T-C, Chen Y-C, Lai J-T (2018) Association of tinnitus and other cochlear disorders with a history of migraines. JAMA Otolaryngology-Head & Neck Surgery 144(8):712\u2013717. https:\/\/doi.org\/10.1001\/jamaoto.2018.0939","journal-title":"JAMA Otolaryngology-Head & Neck Surgery"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01468-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T10:05:01Z","timestamp":1663322701000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01468-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01468-y","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Oral consent was obtained from all participants over the phone after the study purpose was explained, and written informed consents were signed by patients who attended the face-to-face interview.\u00a0The study was performed in accordance with the Helsinki declaration, and the Beni-Suef University hospital research ethical committee approved the study (approval number is FMBSUREC\/07062022\/Tawfik).Authors report that the content has not been published or submitted for publication elsewhere. All authors are in agreement with the content of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}